Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Methionine synthase A2756G polymorphism and breast cancer risk: a meta-analysis involving 18,953 subjects.

Breast cancer research and treatment - 1 Aug 2010

Lu Meiping, Wang Feng, Qiu Jinrong

Abstract excerpt

The A2756G polymorphism in the methionine synthase (MTR) gene has been implicated in breast cancer risk. However, the published findings are inconsistent. We therefore performed a meta-analysis to investigate this relationship. Eleven published case-control studies, including 8,438 breast cancer cases and 10,515 controls were identified. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to assess the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to MTR gene

Share to Genetic Predisposition to Disease

Share to Polymorphism, Single Nucleotide

Share to Risk Factors

Share to White People

Source

Identifiers

PMID: 20111902
DOI: 10.1007/s10549-010-0755-9

Genes

MTR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Methionine synthase A2756G polymorphism and breast cancer risk: a meta-analysis involving 18,953 subjects.PMID 20111902Read ↗

Methionine synthase A2756G polymorphism and breast cancer risk: an up-to-date meta-analysis.Semantic proximity Read ↗

Methionine synthase A2756G polymorphism and cancer risk: a meta-analysis.Semantic proximity Read ↗

MTRR A66G polymorphism and breast cancer risk: a meta-analysis.Semantic proximity Read ↗

Methionine synthase reductase A66G polymorphism is not associated with breast cancer susceptibility - a meta-analysis.Semantic proximity Read ↗

Role of polymorphism of methyltetrahydrofolate-homocysteine methyltransferase (MTR) A2756G and breast cancer risk.Semantic proximity Read ↗

Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.Semantic proximity Read ↗

MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.Semantic proximity Read ↗

MTHFR 677C>T polymorphism and the risk of breast cancer: evidence from an original study and pooled data for 28031 cases and 31880 controls.Semantic proximity Read ↗

ASSOCIATION OF MTHFR A1298C POLYMORPHISM WITH BREAST CANCER AND/OR OVARIAN CANCER RISK: AN UPDATED META-ANALYSIS.Semantic proximity Read ↗

Association between MTHFR gene 1298A>C polymorphism and breast cancer susceptibility: a meta-analysis based on 38 case-control studies with 40,985 subjects.Semantic proximity Read ↗

Association of 677 C>T (rs1801133) and 1298 A>C (rs1801131) polymorphisms in the MTHFR gene and breast cancer susceptibility: a meta-analysis based on 57 individual studies.Semantic proximity Read ↗

Methionine synthase A2756G polymorphism and lymphoma risk: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.